Mitiglinide
- Generic Name
- Mitiglinide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H25NO3
- CAS Number
- 145375-43-5
- Unique Ingredient Identifier
- D86I0XLB13
- Background
Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.
- Indication
用于改善2型糖尿病患者餐后高血糖(仅限用于经饮食、运动疗法不能有效控制血糖的患者或在饮食、运动疗法的基础上加用α-葡萄糖苷酶抑制剂后仍不能有效控制血糖的患者)。
- Associated Conditions
- Blood Glucose, Postprandial, Type 2 Diabetes Mellitus
- Associated Therapies
- -
Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- Orient Europharma Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT04349696
- Locations
- 🇨🇳
Chiayi Chang Gung Memorial Hospital, Chiayi City, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Zhongda Hospital
- Target Recruit Count
- 248
- Registration Number
- NCT02143765
- Locations
- 🇨🇳
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
🇨🇳The Second People's Hospital of Huai'an, Huai'an, Jiangsu, China
🇨🇳Xuzhou Central Hospital, Xuzhou, Jiangsu, China
Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
- Conditions
- Interventions
- First Posted Date
- 2011-08-24
- Last Posted Date
- 2011-09-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT01422590
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 145
- Registration Number
- NCT01037842
- Locations
- 🇰🇷
Kyungpook National University School of Medicine, Daegu, Korea, Republic of
🇰🇷Yonsei University College of Medicine, Seoul, Korea, Republic of
🇰🇷Chungnam National University College of Medicine, Daejeon, Korea, Republic of
Glufast On Insulin Glargine Trial in Type 2 DM
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- JW Pharmaceutical
- Target Recruit Count
- 167
- Registration Number
- NCT00663884
- Locations
- 🇰🇷
The Catholic Univ. of Korea, Kangnam ST. Mary's Hospital, Seoul, Korea, Republic of
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- Elixir Pharmaceuticals
- Target Recruit Count
- 367
- Registration Number
- NCT00519142
- Locations
- 🇵🇷
Elixir Study Site, Fajardo, Puerto Rico
🇵🇷Elixir Study Site(s), San Juan, Puerto Rico
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2008-10-21
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 291
- Registration Number
- NCT00461617
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.